Age‐related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild‐type mice
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
We assessed baseline and KCl‐stimulated glutamate release by using microdialysis in freely moving young adult (7 months) and middle‐aged (17 months) transgenic mice carrying mutated human amyloid precursor protein and presenilin genes (APdE9 mice) and their wild‐type littermates. In addition, we assessed the age‐related development of amyloid pathology and spatial memory impaired in the water maze and changes in glutamate transporters. APdE9 mice showed gradual spatial memory impairment between 6 and 15 months of age. The stimulated glutamate release declined very robustly in 17‐month‐old APdE9 mice as compared to 7‐month‐old APdE9 mice. This age‐dependent decrease in stimulated glutamate release was also evident in wild‐type mice, although it was not as robust as in APdE9 mice. When compared to individual baselines, all aged wild‐type mice showed 25% or greater increase in glutamate release upon KCl stimulation, but none of the aged APdE9 mice. There was an age‐dependent decline in VGLUT1 levels, but not in the levels of VGLUT2, GLT‐1 or synaptophysin. Astrocyte activation as measured by glial acidic fibrillary protein was increased in middle‐aged APdE9 mice. Blunted pre‐synaptic glutamate response may contribute to memory deficit in middle‐aged APdE9 mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 2×
“Synaptic dysfunction is increasingly viewed as an early manifestation of Alzheimer’s disease (AD) and a major correlate of cognitive impairment (Terry et al. 1991).”
BackgroundSELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · cited 1×
“While cholinergic depletion is an established hallmark in AD ( Davies and Maloney 1976 ) and also detected in amyloid producing transgenic amyloid precursor protein (APP) mutant mice (Wong et al., 1999), less is known about changes in glutamatergic neurotransmission.”
BackgroundJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · cited 1×
“…by co-injection of chimeric mouse/human APPswe (mouse APP695 harboring a human Ab domain and mutations K595N and M596L linked to Swedish familial AD pedigrees) and human PS1-dE9 (deletion of exon 9) vectors controlled by independent mouse prion protein promoter elements (Jankowsky et al. 2004).”
BackgroundAMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Wojcik, S. M., Rhee, J. S., Herzog, E., Sigler, A., Jahn, R., Takamori, S., Brose, N., & Rosenmund, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401764101 · Cited by 509 · cited 2×
“Age-related decrease in glutamate transporter levels may not be sufficient to abolished stimulated glutamate release in APdE9 mice The vesicular glutamate transporters have an important role in the release of glutamate from pre-synaptic vesicles (Wojcik et al. 2004; Wilson et al. 2005).”
BackgroundExcitatory amino acids and Alzheimer's disease
Greenamyre, J. T., & Young, A. B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90143-7 · Cited by 484 · cited 10×
“In this set of samples, actinnormalized GFAP levels increased with age in APdE9 mice 2007 The Authors Journal Compilation 2007 International Society for Neurochemistry, J. Neurochem.”
InfluentialBeyond the role of glutamate as a neurotransmitter
Nedergaard, M., Takano, T., & Hansen, A. J. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn916 · Cited by 450
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses
Almeida, C. G., Tampellini, D., Takahashi, R. H., Greengard, P., Lin, M. T., Snyder, E. M., & Gouras, G. K. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.008 · Cited by 397 · cited 4×
“…neurons (transfected or derived from APPswe mutant mice) have reported significant alternations in post-synaptic compartments because of beta-amyloid (Ab) accumulation, including reduced spine density, and number of PSD-95 and GluR1 receptor levels (Almeida et al. 2005; Hsieh et al. 2006).”
BackgroundInfluentialGlutamatergic neurotransmission in aging: a critical perspective
Segovia, G., Porras, A., Del Arco, A., & Mora, F. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00225-6 · Cited by 377 · cited 2×
“…105, 584–594 2007 The Authors Age-related changes in transmitter versus metabolic pool of glutamate Our finding of unchanged basal glutamate levels with aging combined with blunted glutamate release in response to K+ stimulation appears at odds with the existing literature (Segovia et al. 2001).”
ResultSavonenko, A., Xu, G. M., Melnikova, T., Morton, J. L., Gonzales, V., Wong, M. P. F., Price, D. L., Tang, F., Markowska, A. L., & Borchelt, D. R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.022 · Cited by 346 · cited 2×
“These mice exhibit first signs of amyloid plaque deposition at 3–4 months of age, although learning impairment occurs only between 12–19 months (Savonenko et al. 2005), suggesting additional non-amyloid factors responsible for learning impairment.”
BackgroundLI, S., MALLORY, M., ALFORD, M., TANAKA, S., & MASLIAH, E. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00008 · Cited by 343 · cited 2×
“In support of this notion, there are reports of reduced levels of excitatory amino acid transporter protein 1 (EAAT-1) in the platelets (Zoia et al. 2004) and EAAT-2 in the frontal cortex ( Li et al. 1997 ), and reduced glutamate uptake activity in the frontal and temporal cortices of AD brains (Procter et al. 1988),…”
BackgroundPresynaptic Regulation of Quantal Size by the Vesicular Glutamate Transporter VGLUT1
Wilson, N. R., Kang, J., Hueske, E. V., Leung, T., Varoqui, H., Murnick, J. G., Erickson, J. D., & Liu, G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3003-04.2005 · Cited by 335 · cited 2×
“Age-related decrease in glutamate transporter levels may not be sufficient to abolished stimulated glutamate release in APdE9 mice The vesicular glutamate transporters have an important role in the release of glutamate from pre-synaptic vesicles (Wojcik et al. 2004; Wilson et al. 2005).”
BackgroundVesicular transmitter release from astrocytes
Montana, V., Malarkey, E. B., Verderio, C., Matteoli, M., & Parpura, V. (2006) · Glia · doi:10.1002/glia.20367 · Cited by 322 · cited 1×
“However, this does not fully guarantee that the source of the glutamate is neuronal, as recent data indicate that astrocytes can also release glutamate from transmitter vesicles in response to increased cytosolic Ca2+ (Montana et al. 2006).”
BackgroundAlzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone
Hyman, B. T., Van Hoesen, G. W., & Damasio, A. R. (1987) · Annals of Neurology · doi:10.1002/ana.410220110 · Cited by 219 · cited 1×
“Several studies have reported reduced tissue levels of glutamate in the brains of AD patients (Hyman et al. 1987; Lowe et al. 1990), and a recent post-mortem study in AD patients found a reduction in the proteins levels of vesicular glutamate transporter 1 (VGLUT1) in both the parietal and…”
BackgroundEvidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease
Procter, A. W., Palmer, A. M., Francis, P. T., Lowe, S. L., Neary, D., Murphy, E., Doshi, R., & Bowen, D. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02983.x · Cited by 197 · cited 2×
“…the platelets (Zoia et al. 2004) and EAAT-2 in the frontal cortex (Li et al. 1997), and reduced glutamate uptake activity in the frontal and temporal cortices of AD brains (Procter et al. 1988), which may lead to elevated extracellular glutamate concentration and render neurons for excitotoxicity.”
BackgroundWong, T. P., Debeir, T., Duff, K., & Cuello, A. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02706.1999 · Cited by 196 · cited 2×
“While cholinergic depletion is an established hallmark in AD (Davies and Maloney 1976) and also detected in amyloid producing transgenic amyloid precursor protein (APP) mutant mice ( Wong et al., 1999 ), less is known about changes in glutamatergic neurotransmission.”
BackgroundKirvell, S. L., Esiri, M., & Francis, P. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03935.x · Cited by 187 · cited 2×
“…tissue levels of glutamate in the brains of AD patients (Hyman et al. 1987; Lowe et al. 1990), and a recent post-mortem study in AD patients found a reduction in the proteins levels of vesicular glutamate transporter 1 (VGLUT1) in both the parietal and occipital cortices (Kirvell et al. 2006).”
BackgroundSoluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
Etcheberrigaray, R., Ito, E., Kim, C. S., & Alkon, D. L. (1994) · Science · doi:10.1126/science.8146663 · Cited by 167 · cited 2×
“…on the cell type, concentration and special species or conformation of the peptide, Ab has been reported to either inhibit (Good et al. 1996; Ye et al. 2003) or augment (Plant et al. 2006) A-type K+ channels or inhibit delayed rectifier K+ channels (Etcheberrigaray et al., 1994; Ye et al. 2003).”
BackgroundAbnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice
Masliah, E., Alford, M. F., Mallory, M. E., Rockenstein, E. M., Moechars, D., & LEUVEN, F. V. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7386 · Cited by 160 · cited 2×
“This study (Masliah et al. 2000) reported a decrease in glial glutamate transporters, glutamate aspartate transporter (similar to human EAAT-1) and GLT-1 (similar to human EAAT-2), which may indicate elevated extracellular glutamate levels in these mice.”
BackgroundBeta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons
Good, T. A., Smith, D. O., & Murphy, R. M. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79570-x · Cited by 131 · cited 2×
“Depending on the cell type, concentration and special species or conformation of the peptide, Ab has been reported to either inhibit (Good et al. 1996; Ye et al. 2003) or augment (Plant et al. 2006) A-type K+ channels or inhibit delayed rectifier K+ channels (Etcheberrigaray et al., 1994; Ye et al.…”
BackgroundAmyloid β peptide as a physiological modulator of neuronal ‘A’-type K+ current
Plant, L. D., Webster, N. J., Boyle, J. P., Ramsden, M., Freir, D. B., Peers, C., & Pearson, H. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.038 · Cited by 116 · cited 1×
“…on the cell type, concentration and special species or conformation of the peptide, Ab has been reported to either inhibit (Good et al. 1996; Ye et al. 2003) or augment (Plant et al. 2006) A-type K+ channels or inhibit delayed rectifier K+ channels (Etcheberrigaray et al., 1994; Ye et al. 2003).”
BackgroundLowe, S. L., Bowen, D. M., Francis, P. T., & Neary, D. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90051-5 · Cited by 94 · cited 1×
“Several studies have reported reduced tissue levels of glutamate in the brains of AD patients (Hyman et al. 1987; Lowe et al. 1990), and a recent post-mortem study in AD patients found a reduction in the proteins levels of vesicular glutamate transporter 1 (VGLUT1) in both the parietal and…”
BackgroundGlutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer’s disease
Zoia, C., Cogliati, T., Tagliabue, E., Cavaletti, G., Sala, G., Galimberti, G., Rivolta, I., Rossi, V., Frattola, L., & Ferrarese, C. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00085-x · Cited by 84 · cited 2×
“In support of this notion, there are reports of reduced levels of excitatory amino acid transporter protein 1 (EAAT-1) in the platelets (Zoia et al. 2004) and EAAT-2 in the frontal cortex (Li et al.”
BackgroundGlutamate Uptake Impairment and Neuronal Damage in Young and Aged Rats In Vivo
Massieu, L., & Tapia, R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031151.x · Cited by 83 · cited 2×
“Finally, we used KCl to promote glutamate release through membrane depolarization, while Massieu and Tapia used a glutamate uptake blocker to increase extracellular glutamate levels (Massieu and Tapia 1997).”
MethodShemer, I., Holmgren, C., Min, R., Fülöp, L., Zilberter, M., Sousa, K. M., Farkas, T., Härtig, W., Penke, B., Burnashev, N., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04733.x · Cited by 82 · cited 2×
“…support of this notion, robust decrease in cortical post-synaptic alpha-amino-3-hydroxy-5-methyl-4isoxazole propionic acid (AMPA) currents compared to those in wild-type mice has been observed in our APdE9 mice, as well as in slices of wild-type mice treated with exogenous Ab (Shemer et al. 2006).”
BackgroundSelf-citationProtofibrils of amyloid β-protein inhibit specific K+ currents in neocortical cultures
Ye, C. P., Selkoe, D. J., & Hartley, D. M. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00068-8 · Cited by 75 · cited 2×
“…on the cell type, concentration and special species or conformation of the peptide, Ab has been reported to either inhibit (Good et al. 1996; Ye et al. 2003) or augment (Plant et al. 2006) A-type K+ channels or inhibit delayed rectifier K+ channels (Etcheberrigaray et al., 1994; Ye et al. 2003).”
BackgroundRegulation of the synthesis of the transmitter glutamate pool
Fonnum, F. (1993) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(93)90012-9 · Cited by 74 · cited 1×
“Furthermore, 70–80% of glutamate in neurons is estimated to reside in the metabolic pool and only 20–30% in glutamatergic nerve terminals (Fonnum 1993).”
BackgroundBell, K. F. S., de Kort, G. J. L., Steggerda, S., Shigemoto, R., Ribeiro‐da‐Silva, A., & Cuello, A. C. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.027 · Cited by 70 · cited 1×
“…has assessed structural alterations in glutamate terminals in APP mutant mice, and reported increased density of glutamatergic presynaptic boutons in both the plaque free and plaque adjacent cortical areas of 4-month-old transgenic mice as compared to non-transgenic controls (Bell et al. 2003).”
BackgroundImpairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice
Machová, E., Jakubík, J., Michal, P., Oksman, M., Iivonen, H., Tanila, H., & Doležal, V. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.029 · Cited by 58 · cited 1×
“In addition, recently we reported reduced levels of vesicular acetylcholine transporter in the same mice at 7 months of age, with advanced reduction of cholinergic synaptic markers by 17 months of age ( Machova et al. 2006 ), providing an interesting reference to possible glutamatergic synaptic changes in the same mou…”
BackgroundSelf-citationZhang, W., Mundy, W. R., Thai, L., Hudson, P. M., Gallagher, M., Tilson, H. A., & Hong, J. (1991) · Hippocampus · doi:10.1002/hipo.450010407 · Cited by 55 · cited 2×
“Whereas one study in 24-month-old Fisher-344 rats (Zhang et al. 1991) reported about 30% reduction in extracellular glutamate concentration in the hippocampus of aged rats, another study found 60% increase in Wistar rats of similar age (Massieu and 0 2 4 6 8 10 6 m 16 m IR a re a % wt…”
BackgroundResultCha, J.-H. J., Farrell, L. A., Ahmed, S. F., Frey, A., Hsiao-Ashe, K. K., Young, A. B., Penney, J. B., Locascio, J. J., Hyman, B. T., & Irizarry, M. C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0330 · Cited by 37 · cited 2×
“Dysregulation of glutamate receptors has also been found in vivo in APPswe mutant mice, albeit the change was an age-related increase in alpha-amino-3-hydroxy-5-methyl-4isoxazole propionic acid (AMPA) receptor binding (Cha et al. 2001).”
BackgroundPresenilins Upregulate Functional K+Channel Currents in Mammalian Cells
Malin, S. A., Guo, W., Jafari, G., Goate, A., & Nerbonne, J. M. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0167 · Cited by 28 · cited 1×
“The APdE9 presenilin mutation itself has been shown to alter outward K+ currents in cultured human cells, although the reports disagree as to whether the change is toward an increase (Malin et al. 1998) or decrease (Plant et al. 2002).”
BackgroundMarutle, A., Unger, C., Hellström‐Lindahl, E., Wang, J., Puoliväli, J. T., Tanila, H., Nordberg, A. K., & Zhang, X. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00546-3 · Cited by 24 · cited 2×
“The tissue was homogenized on ice in 7 volumes of 20 mmol/L Tris–HCl buffer, pH 8.5, containing a cocktail of protease inhibitors (COMPLETE , Roche Diagnostics, Basel, Switzerland; Marutle et al. 2002).”
BackgroundMethodInfluentialSelf-citation
Cited by
Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy
Minkeviciene, R., Rheims, S., Dobszay, M. B., Zilberter, M., Hartikainen, J., Fülöp, L., Penke, B., Zilberter, Y., Harkany, T., Pitkänen, A., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5215-08.2009 · Cited by 652
Self-citationFSH blockade improves cognition in mice with Alzheimer’s disease
Xiong, J., Kang, S. S., Wang, Z., Liu, X., Kuo, T.-C., Korkmaz, F., Padilla, A., Miyashita, S., Chan, P., Zhang, Z., et al. (2022) · Nature · doi:10.1038/s41586-022-04463-0 · Cited by 329
Lonnemann, N., Hosseini, S., Marchetti, C., Skouras, D. B., Stefanoni, D., D’Alessandro, A., Dinarello, C. A., & Korte, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009680117 · Cited by 298
“However, no deficits were found at the age of 6 mo (34, 35).”
Graphene quantum dots conjugated neuroprotective peptide improve learning and memory capability
Xiao, S., Zhou, D., Luan, P., Gu, B., Feng, L., Fan, S., Liao, W., Fang, W., Yang, L., Tao, E., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.021 · Cited by 169
Microglia change from a reactive to an age-like phenotype with the time in culture
Caldeira, C., Oliveira, A. F., Cunha, C., Vaz, A. R., Falcão, A. S., Fernandes, A., & Brites, D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00152 · Cited by 156
“However, several studies have shown lower glutamate concentration in older subjects when compared to younger individuals (Kaiser et al., 2005; Sailasuta et al., 2008; Chang et al., 2009) and an age-dependent decline of glutamate release in mice (Minkeviciene et al., 2008).”
Background
Metadata
- Authors
- Minkeviciene, R., Ihalainen, J., Malm, T., Matilainen, O., Keksa‐Goldsteine, V., Goldsteins, G., Iivonen, H., Leguit, N., Glennon, J., Koistinaho, J., Banerjee, P., & Tanila, H.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-11-27
- Volume
- 105
- Issue
- 3
- Pages
- 584-594
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2038572225
- Cited by
- 208
- References
- 33
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.